• Head_banner_01

ភាពមិនបរិសុទ្ធនៃអាស៊ីតអាមីណូប្រើសម្រាប់ប្រូតេអ៊ីនសំយោគ

ការពិពណ៌នាខ្លី:

NO

ផលិតផល

cas ទេ

1

FMoc-D-Ala-D-Ala-Oo

NA

2

fmoc-β-ala-d-ala-y

NA

3

FMoc-Arg (PBF) -ARG (PBF) -oh

NA


ពត៌មានរបស់ផលិតផល

ស្លាកផលិតផល

ពត៌មានរបស់ផលិតផល

NO

ផលិតផល

cas ទេ

សូចនាករគុណភាពសំខាន់ៗ

ភាពបរិសុទ្ធ

អតិបរមា។

ដេលធេវី

សំណល់សារធាតុរំលាយសរុប

សមនើម

1

fmoc-β-ala-ala -h

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

FMoc-D-Ala-D-Ala-Oo

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

fmoc-β-ala-d-ala-y

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

FMoc-Arg (PBF) -ARG (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

FMOC-β-Ala-alg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

FMoc-D-Arg (PBF) -D-Arg (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

FMOC-β-Ala-D-Arg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

FMOC-Homoarg (PBF) -homooarg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

FMOC-β-Ala-homoarg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

fmoc-asn (trt) -asn (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

fmoc-β-ala-asn (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

FMOC-ASP (OTBU) -App (OTBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

FMOC-β-Ala-Asp (OTBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

FMOC-CYS (TRT) -CYS (TRT) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

fmoc-β-ala-cys (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

FMOC-CYS (ACM) -CYS (ACM) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

fmoc-β-ala-cys (acm) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

fmoc-gln (trt) -gln (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

fmoc-β-ala-gln (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

FMoc-Glu (OTBU) -Glou (OTBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

FMOC-β-Ala-Glu (OTBU) -oh.h2o

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

fmoc-β-ala-gly-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

FMOC-របស់គាត់ (TRT) -his (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

fmoc-β-ala-ala (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

FMOC-Ile-Ole-OO

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

FMOC-β-Ala-le-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

fmoc-leu-leu-yo

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

fmoc-β-ala-leu-yo

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

fmoc-d-leu-d-leu-oo

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

FMOC-β-Ala-D-Leu-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

FMOC-LYS (BOC) -lys (Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

FMOC-β-Ala-Lys (Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

FMOC-LYS (ALECH) -lys (ALOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

fmoc-β-ala-lys (ALACH) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

FMOC- Met-Met - អូ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

fmoc-β-met -h-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

FMOC-Orn (Boc) -orn (Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

fmoc-β-ala-orn (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

fmoc-phe-phe-y

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

fmoc-β-ala-phe-y

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

fmoc-d-phe-d-phe-y

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

FMOC-β-ala-d-phe-y

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

FMoc-Pro-Oh Pro-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

FMOC-β-Ala-Pro-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

FMOC-SER (TBU) -Ser (TBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

fmoc-β-ala-ser (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

FMOC-SER (TRT) -Ser (TRT) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

fmoc-β-ala-sere (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

FMOC-THR (TBU) - TBU (TUU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

fmoc-β-ala-tr (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

FMOC-TRP (BOC) -Trp (Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

fmoc-β-ala-trp (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

FMOC-D-TRP (BOC) -D-TRP (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

FMOC-β-Ala-D-TRP (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

FMOC-TYR (TBU) -TYR (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

fmoc-β-ala-tyr (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

fmoc-d-tyr (et) -d-tyr (et) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

fmoc-β-ala-d-tyr (et) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

FMOC-TYR (ខ្ញុំ) -thtyr (ខ្ញុំ) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

fmoc-β-ala-tyr (ខ្ញុំ) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

FMOC-Val-Oo

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

FMOC-β-ala-val-oo

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

FMOC-D- Cit-D-D-CIT-OO

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

FMOC-β-Ala-D-Cit-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

FMOC-β-Ala-Dab-OO

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

FMOC- (3- (2-naphththyl) -d-ala) 2 -h

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

FMOC-β-Ala-3- (2-naphththyl) -d-ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

FMOC- (3- (3- 3- Pyridinyl) -d-ala) 2 -h

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

FMOC-β-Ala-3- (3-Pyridinyl) -d-ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

FMOC- (4-chloro-d-phe) 2- អូ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

FMOC-β-Ala-4-chloro-d-phe-y

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

FMOC- (D-4APAH (TBUCBM) 2- អូ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

FMOC-β-Ala-D-4APH (TBUCBM) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

FMOC-AP (L-HOL) -APH (L-HOH) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

FMOC-β-Ala-Ap (L-HOL) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

FMoc-Lys (ipr, Boc) គឺ (អាយភីអា, បូក) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

fmoc-β-ala-lys (ipr, boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

fmoc-β-ala-aeea-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

fmoc-aib-aib -h-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

fmoc-β-ala-aib -h-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

FMoc-Arg-Oh OH

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-ARG (PBF) -oh

2001115-86-86-86-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

FMoc-D-Arg-Oh OH

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

HD-ARG (PBF) -oh

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

FMOC-Homoarg-Oh.HCL

208174-14-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-Homoarg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

fmoc-d-homoarg -h of អូ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

HD-Homoarg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

fmoc-asn -h

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-ASN (TRT) -oh

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

fmoc-asp -ho

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-ASP (OTBU) -oh

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

FMOC-CYS-OO

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-CYS (TRT) -oh

2799/7/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-CYS (ACM) -oh.hcl

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

fmoc-gln-oh

71989-20-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-GLN (TRT) -oh

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

fmoc-glu-oo

121343-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H-GLU (OTBU) -oh.h2o

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

fmoc-ho oh oh

116611-64-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយរ 101

H-H-Her (Trt) -oh

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយរទៅវិញន៍ 102

boc-ho-oh

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

បីកុន

fmoc-lys -h

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយរទៅវិញន៍នៈ

H-LYS (BOC) -oh

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105 បីនាក់

H-LYS (ALACO) -OH

6298/3/9/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយរ / រិយសង្កាម

fmoc-orn-o.hcl

ឆ្នាំ 201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយរទៅវិញន៍ 107

H-orn (Boc) -oh

13650-49-2-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយញដោយយរវ័យ 108

FMOC-Ser-OO OH

73724-45-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

ាប់បីហិប

h-ser (tbu) -oh

18822-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

មយយ

h-sere (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយយត

FMOC-OR-OH.H2O

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយរទៅវិញន៍

H-THR (TBU) -oh

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អយតដោ

fmoc-trp -h

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយញវិញ

H-TRP (BOC) -oh

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយញហេតុ

fmoc-d-trp -h

86123-11-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយយ

HD-TRP (BOC) -oh

201290-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយយតមនត់

fmoc-tyr-oh អូ

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អយយ

H-TYR (TBU) -oh

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមនយយយយ 99

FMoc-D-Tyr-Oh OH

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

HD-TYR (et) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-TYR (ខ្ញុំ) -oh.hcl

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

fmoc-d-4APH (CBM) -oh

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយរទៅវិញន៍ផ្លើរ

HD-4APH (TBUCBM) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

fmoc-lys (ipr) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមយរផ្លើ

H-LYS (iPR, Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

អមបី

ការយកមកតុតាត់

Gustolex ផ្តល់នូវផលិតផលដែលមានគុណភាពខ្ពស់ប្រសិនបើគុណភាពផលិតផលត្រូវបានលើកឡើងដោយអតិថិជនក្នុងកំឡុងពេលដែលត្រូវការជាមួយភ័ស្តុតាងគ្រប់គ្រាន់យើងនឹងផ្តល់ការវិភាគនិងវាយតម្លៃដើម្បីកេះនីតិវិធីនៃសំណង។

ផលិតកម្ផ

សមត្ថភាពផលិតផលឱសថបានមកដល់សុន្ទរកថាថ្នាក់ទរសមត្ថភាពផលិតផលិតផលគីមីឈានដល់ 100 ធាម + សមត្ថភាពត្រូវបានបំពាក់យ៉ាងល្អដើម្បីបម្រើអតិថិជនទូទាំងពិភពលោក។

ស្រាវជ្រាវនិងអភិវឌ្ឍន៍

ជារៀងរាល់ឆ្នាំមានផែនការបង្កើតដោយក្រុម R & D ដើម្បីអភិវឌ្ឍផលិតផលថ្មីៗផ្សេងៗគ្នានៅពេលគោលដៅដែលបានកំណត់នោះសមាជិកទាំងអស់នៅក្នុងក្រុមនឹងត្រូវបន្តទទួលខុសត្រូវរបស់ខេភីនិងគោលនយោបាយលើកទឹកចិត្ត។


  • មុន:
  • បន្ទាប់:

  • សរសេរសាររបស់អ្នកនៅទីនេះហើយផ្ញើវាមកយើង